Clinical trial
Mi2000 TICI - Post-market Implantation Study
NCT07897318 is registered in ClinicalTrials.gov with MED-EL Elektromedizinische Geräte GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mi2000 TICI - Post-market Implantation Study
- Lead sponsor
- MED-EL Elektromedizinische Geräte GmbH
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 11, 2026
- Completion date
- January 31, 2029
- Enrollment
- 22 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
cochlear implantation, hearing loss, binaural
Arms
As registered; 1 arm.
-
TICI recipients
Participants in this clinical investigation will be implanted with an Mi2000 TICI totally cochlear implant
Primary endpoints
Registered primary outcome measures; 2 primary.
-
Word Test in Quiet
Word recognition in quiet, on a scale from 0 to 100% correct, higher scores indicate better outcomes
-
Sentence Test in Noise
Oldenburg Matrix Test, results measured in dB signal-to-noise ratio (SNR) with a range of +30 to -10 dB SNR, lower values indicating better outcomes
Lead sponsor's other trials
MED-EL Elektromedizinische Geräte GmbH, most recent start first.
+33 more trials See the organization page
Similar trials
Same condition (Hearing Loss) and phase, most recent start first.
+473 more trials See the condition page